We recently compiled a list of the 13 Best Forever Stocks to Buy Right Now. In this article, we are going to take a look at ...

Johnson & Johnson (JNJ) stock in focus as limited rollout of Varipulse heart device resumes after a safety review prompted by ...

Genoa Area Chamber of Commerce Executive Director Krissy Johnson heralded efforts made by local businesses she said helped ...

Johnson & Johnson said on Friday it resumed the limited market release of its Varipulse heart device in the United States ...

We recently compiled a list of the Jim Cramer Discussed These 11 Stocks Recently. In this article, we are going to take a ...

A recent pause in U.S. sales of Varipulse is hampering the company’s bid to catch up in one of the industry’s fastest-growing ...

Johnson & Johnson and Sanofi said that while the vaccine showed no safety concerns, it did not meet the necessary ...

Johnson & Johnson is considering selling its stroke care unit, Cerenovus, in a potential $1 billion deal as part of its ...

Pharmaceutical giant Johnson & Johnson (JNJ) is planning to sell its stroke care business called “Cerenovus” for $1 billion ...

Johnson & Johnson is acquiring biopharmaceutical company Intra-Cellular Therapies for $14.6 billion. It has an approved depression and schizophrenia treatment that could generate $5 billion in ...

Here's the skinny on that quarter and whether the rest of the year will be healthy enough to rank the company's stock as a buy. To give some idea of the sheer size of Johnson & Johnson ...

The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including NVIDIA Corp. (NVDA), Johnson ...